Status:
COMPLETED
Pivotal Response Group Treatment for Parents of Young Children With Autism
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Autism Speaks
Conditions:
Autistic Disorder
Eligibility:
All Genders
2-6 years
Phase:
NA
Brief Summary
This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism. Research has demonstrated that behavioral in...
Detailed Description
This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism. Research has demonstrated that behavioral in...
Eligibility Criteria
Inclusion
- Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview - Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS), Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), and expert clinical opinion
- Outpatients between 2.0 and 6 years of age of either gender
- Children of all cognitive levels will be included as long as they are able to participate in the testing procedures to the extent that valid standard scores can be obtained
- Language delay as measured by the Preschool Language Scale 4th ed. (PLS-4)
- Participants must have the ability to make meaningful vocalizations, defined as the ability to make contingent vocalizations when prompted (i.e., vocal sound showing intent to communicate, but not necessarily clear words)
- Stable psychotropic medication(s) or biomedical interventions for at least one month prior to baseline measurements with no anticipated changes during study participation
- Stable behavioral treatment (Applied Behavioral Analysis, Floortime, or other interventions), speech therapy, and school placement for at least 2 months prior to baseline measurements with no expected changes during study participation
- No more than 60 minutes of 1:1 speech therapy per week
- The availability of at least one parent who can consistently participate in the group treatment and related activities of the research study
- Be male or female in good medical health
- Will be starting PRTG after the first magnetic resonance image (MRI) scan has occured and, if agreeable, blood draw or saliva sample
- Parents intend on continuing PRTG for a minimum of 12 weeks
- Parents must be 18 years of age or older.
Exclusion
- A current or life-time diagnosis of severe psychiatric disorder (e.g., bipolar disorder…)
- A genetic abnormality, such as Fragile X, based on genetic testing, done as indicated
- Presence of active medical problem (e.g., unstable seizure disorder or heart disease)
- Participants taking psychotropic medications will not be included if their medications have not been stable for over a week
- Parents who do not have the ability to videotape parent and child interactions on a weekly basis
- Parents who are not willing to implement intervention strategies for at least one hour a day
- Parents who plan to alternate which parent attends the group sessions.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01881750
Start Date
July 1 2010
End Date
July 1 2012
Last Update
August 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305